Comparative Effectiveness of Nintedanib and Pirfenidone in Patients Diagnosed With Idiopathic Pulmonary Fibrosis

被引：0
作者：
Shankar, D. [1 ]
Law, A. [1 ]
Walkey, A. J. [1 ]
Hawkins, F. J. [1 ]
Alysandratos, K. [2 ]
Wilson, K. C. [1 ]
Bosch, N. A. [1 ]
机构：
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Pulm, Boston, MA 02118 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2481
引用
收藏
页数：2
相关论文
共 50 条
[21]   Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis Reply [J].
Vancheri, Carlo ;
Kreuter, Michael ;
Richeldi, Luca ;
Quaresma, Manuel ;
Stowasser, Susanne ;
Wuyts, Wim A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (08) :1105-1106
[22]   A comparison of pirfenidone versus nintedanib for the management of idiopathic pulmonary fibrosis [J].
Naqvi, Marium ;
D'Ancona, Grainne ;
West, Alex .
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[23]   Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis [J].
Flaherty, Kevin R. ;
Fell, Charlene D. ;
Huggins, J. Terrill ;
Nunes, Hilario ;
Sussman, Robert ;
Valenzuela, Claudia ;
Petzinger, Ute ;
Stauffer, John L. ;
Gilberg, Frank ;
Bengus, Monica ;
Wijsenbeek, Marlies .
EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (02)
[24]   Nintedanib and Pirfenidone as a Bridge to Lung Transplant in Idiopathic Pulmonary Fibrosis [J].
Li, D. ;
Mason, W. ;
Hoy, H. ;
Robbins, I. ;
Loyd, J. ;
Lancaster, L. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[25]   TRENDS IN NINTEDANIB AND PIRFENIDONE UTILIZATION FOR IDIOPATHIC PULMONARY FIBROSIS IN AUSTRALIA [J].
Cox, I ;
De Graaff, B. ;
Corte, T. ;
Glaspole, I ;
Chambers, D. ;
Moodley, Y. ;
Teoh, A. ;
Walters, E. ;
Palmer, A. .
RESPIROLOGY, 2021, 26 :92-92
[26]   Cost-effectiveness of nintedanib versus pirfenidone in the treatment of idiopathic pulmonary fibrosis: a systematic review [J].
Rezapour, Aziz ;
Veysi-Sheikhrobat, Mohammad ;
Souresrafil, Aghdas ;
Moeini, Sajad ;
Roghani, Tayebe ;
Sayyad, Abdollah ;
Tahmasebi-Ghorrabi, Ahmad .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025, 25 (05) :661-669
[27]   Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients [J].
Fournier, D. ;
Jouneau, S. ;
Bouzille, G. ;
Polard, E. ;
Osmont, M. N. ;
Scailteux, L. M. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 :77-78
[28]   Utilization of Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of US Claims Data [J].
Viscidi, Emma ;
Wang, Nasha ;
Hall, Susan ;
Gallagher, Diana ;
Eaton, Susan ;
Dilley, Anne .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 :577-578
[29]   Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis [J].
Marcos Ribes, Borja ;
Sancho-Chust, Jose N. ;
Talens, Amparo ;
Arlandis, Mar ;
Herraiz, Paola ;
Chiner, Eusebi ;
Aznar, Teresa .
EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (06) :350-354
[30]   Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients [J].
Fournier, Dorine ;
Jouneau, Stephane ;
Bouzille, Guillaume ;
Polard, Elisabeth ;
Osmont, Marie-Noëlle ;
Scailteux, Lucie-Marie .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 76
12345